Anchored in Compliance: 340B Pearls for Covered Entities Webinar

@scope { .alert-content-wrapper { background-color: var(--apexus-color-smog, #ffc42733); padding-top: var(--apexus-content-gap-related, 0.5rem); padding-bottom: var(--apexus-content-gap-related, 0.5rem); } .alert-content { color: var(--apexus-color-red, #b51718); line-height: var(--apexus-line-height-thin, 1.15); overflow-wrap: break-word; box-sizing: border-box; max-width: var(--apexus-page-width, 80vw); padding-left: var(--apexus-page-padding, 15px); padding-right: var(--apexus-page-padding, 15px); margin-right: auto; margin-left: auto; } .alert-content > * { margin-right: var(--apexus-content-gap-related, 0.5rem); display: block; } a { color: var(--apexus-color-blue, #0ca0db); text-decoration: none; } a:hover { text-decoration: underline; color: var(--apexus-color-blue, #0ca0db); cursor: pointer; } .details-action-button { margin-left: var(--apexus-content-gap-related, 0.5rem); } } /* Firefox and iOS compatibility */ @supports (-moz-appearance: none) or (hanging-punctuation: none) { .alert-content-wrapper { background-color: var(--apexus-color-smog, #ffc42733); padding-top: var(--apexus-content-gap-related, 0.5rem); padding-bottom: var(--apexus-content-gap-related, 0.5rem); } .alert-content { color: var(--apexus-color-red, #b51718); line-height: var(--apexus-line-height-thin, 1.15); overflow-wrap: break-word; box-sizing: border-box; max-width: var(--apexus-page-width, 80vw); padding-left: var(--apexus-page-padding, 15px); padding-right: var(--apexus-page-padding, 15px); margin-right: auto; margin-left: auto; } .alert-content > * { margin-right: var(--apexus-content-gap-related, 0.5rem); display: block; } a { color: var(--apexus-color-blue, #0ca0db); text-decoration: none; } a:hover { text-decoration: underline; color: var(--apexus-color-blue, #0ca0db); cursor: pointer; } .details-action-button { margin-left: var(--apexus-content-gap-related, 0.5rem); } }

Javascript is not enabled. Please enable it for the best experience or contact Apexus Answers for further assistance.

340B University
Virtual Events
Anchored in Compliance: 340B Pearls for Covered Entities Webinar

New: Pharmacy Continuing Education (CE) Credit Available

340B Program administration involves several interconnected considerations, including identifying covered outpatient drugs, understanding 340B price calculations, and applying HRSA’s patient definition. This webinar will explore these topics through practical examples and case studies.

Join the HRSA 340B Prime Vendor to build your understanding of these key 340B concepts and their application in practice. The webinar will also highlight Prime Vendor Program resources, including self-audit tools that can support ongoing program oversight.

Objectives:

Describe key considerations for what qualifies as a covered outpatient drug (COD).
Recognize how the 340B price is calculated and made available to covered entities.
Identify operational practices that support compliant application of HRSA’s patient definition.

Speakers:

Michael Peters, PharmD, MBA, BCPS, 340B ACE

Director, 340B Compliance

Apexus

Sara Dwivedi, PharmD, MS, 340B ACE

Associate Director, 340B Compliance

Apexus

Attend this live webinar to explore these topics in greater detail. Questions will be answered by our 340B subject matter experts via the interactive Q&A feature available in Zoom. Registrants will receive a copy of the presentation slides afterward. The webinar will not be recorded.

Target Audience: Covered entities

Participant Knowledge Level: Intermediate

CE Credit: 1.0 contact hour (0.1 CEU)

Event Date: Tuesday, November 17, 2026 | 12:00–1:00 p.m. CT

Joint Accreditation Statement

Jointly Accredited Provider Interprofessional Continuing Education

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and Apexus. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Pharmacy Continuing Education
Partners designates this continuing education activity for 1.0 contact hour(s) (0.1 CEU) of the Accreditation Council for Pharmacy Education.

For questions, or to request additional information regarding specific 340B Prime Vendor Program services or programs offered by Apexus, please see contact information below:

apexusanswers@340Bpvp.com

888-340-BPVP (2787)

8:00 am-5:00 pm CT

340B Prime Vendor Program (PVP) Tools

Self-Audit: Prevention of Diversion (CHC/FQHC)

This tool provides an example of a self-audit best practice for community health centers (CH/FQ/FQHC/FQHCLA/NH) to comply with 340B requirements regarding the prevention of diversion.

Self-Audit: Prevention of Diversion (CAH/RRC/SCH)

This tool provides a sample self-audit for rural hospitals (CAH/RRC/SCH) to comply with 340B requirements regarding the prevention of diversion.

Self-Audit: Prevention of Diversion and GPO Violation (DSH/PED/CAN)

This tool provides a sample self-audit for hospitals subject to the GPO Prohibition (DSH/PED/CAN) to comply with 340B requirements regarding the prevention of diversion and GPO Prohibition violations.